RS63941B1 - Kompozicije sa mešavinom alergena i postupci za njihovu upotrebu - Google Patents

Kompozicije sa mešavinom alergena i postupci za njihovu upotrebu

Info

Publication number
RS63941B1
RS63941B1 RS20230085A RSP20230085A RS63941B1 RS 63941 B1 RS63941 B1 RS 63941B1 RS 20230085 A RS20230085 A RS 20230085A RS P20230085 A RSP20230085 A RS P20230085A RS 63941 B1 RS63941 B1 RS 63941B1
Authority
RS
Serbia
Prior art keywords
methods
same
mixed allergen
allergen compositions
compositions
Prior art date
Application number
RS20230085A
Other languages
English (en)
Inventor
Kari C Nadeau
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS63941(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of RS63941B1 publication Critical patent/RS63941B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20230085A 2015-02-20 2016-02-19 Kompozicije sa mešavinom alergena i postupci za njihovu upotrebu RS63941B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562119014P 2015-02-20 2015-02-20
EP16753171.4A EP3258962B1 (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same
PCT/US2016/018731 WO2016134291A2 (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same

Publications (1)

Publication Number Publication Date
RS63941B1 true RS63941B1 (sr) 2023-02-28

Family

ID=56689334

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20230085A RS63941B1 (sr) 2015-02-20 2016-02-19 Kompozicije sa mešavinom alergena i postupci za njihovu upotrebu

Country Status (23)

Country Link
US (4) US10064936B2 (sr)
EP (2) EP4186521A1 (sr)
JP (3) JP6859261B2 (sr)
KR (1) KR20170117562A (sr)
CN (2) CN107405394B (sr)
AU (2) AU2016219793C1 (sr)
BR (1) BR112017017894A2 (sr)
CA (1) CA2977127A1 (sr)
DK (1) DK3258962T3 (sr)
ES (1) ES2937287T3 (sr)
FI (1) FI3258962T3 (sr)
HK (1) HK1247854A1 (sr)
HU (1) HUE061576T2 (sr)
IL (1) IL253976B1 (sr)
LT (1) LT3258962T (sr)
MA (1) MA41558B1 (sr)
MX (2) MX2017010697A (sr)
PL (1) PL3258962T3 (sr)
PT (1) PT3258962T (sr)
RS (1) RS63941B1 (sr)
SG (2) SG11201706734SA (sr)
SI (1) SI3258962T1 (sr)
WO (1) WO2016134291A2 (sr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CN107405394B (zh) 2015-02-20 2021-12-14 斯坦福大学托管董事会 混合变应原组合物及其使用方法
US10143742B2 (en) * 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2016138030A2 (en) * 2015-02-23 2016-09-01 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
JP7339886B2 (ja) * 2016-11-21 2023-09-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 液体アレルゲン組成物及びその製造方法
US10656145B2 (en) 2016-12-09 2020-05-19 General Mills, Inc. Detection of allergens using surface-enhanced raman scattering
CA3050093A1 (en) * 2017-01-13 2018-07-19 Aimmune Therapeutics, Inc. Methods of manufacture of nut flours and formulations for oral immunotherapy
FR3062797A1 (fr) * 2017-02-10 2018-08-17 Centre Hospitalier Et Universitaire De Clermont-Ferrand Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
US20180360951A1 (en) * 2017-06-20 2018-12-20 Evros Vassiliou Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d
US11382934B2 (en) * 2017-07-18 2022-07-12 Before Brands, Inc. Methods for making mixed allergen compositions
WO2019112808A1 (en) 2017-12-06 2019-06-13 Prollergy Corporation Composition and method for reducing allergic response
EP3886899A1 (en) * 2018-11-30 2021-10-06 Alladapt Immunotherapeutics, Inc. Methods for making mixed allergen compositions
EP3897170A1 (en) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Drinkable infant compositions
WO2020154476A1 (en) 2019-01-23 2020-07-30 Before Brands, Inc. Methods for making mixed allergen compositions
US20200236982A1 (en) * 2019-01-28 2020-07-30 Lil Mixins, Llc Tree nut powder formulation
US11324247B2 (en) 2019-06-13 2022-05-10 Lil Mixins, Llc Food products for infants and babies and method of making same
US11154082B2 (en) 2019-06-13 2021-10-26 Lil Mixins, Llc Egg product for infants and babies and method of making same
US20240151702A1 (en) * 2021-03-05 2024-05-09 Societe Des Produits Nestle S.A. Methods of making and assessing allergenic tree nut compositions
US11154081B1 (en) 2021-03-16 2021-10-26 Lil Mixins, Llc Well cooked egg powder
US11439173B1 (en) 2021-09-22 2022-09-13 Lil Mixins, Llc Low allergenicity well cooked food powder

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB9323483D0 (en) 1993-11-13 1994-01-05 Cerestar Holding Bv Edible composition and a process for its preparation
AU1951201A (en) 1999-12-06 2001-06-12 Mount Sinai School Of Medicine Of The City University Of New York, The Peptide antigens
US6716471B2 (en) 2000-05-12 2004-04-06 Sigmund Kramer Peanut powder compositions and methods of making same
FR2822709B1 (fr) 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
ATE503494T1 (de) 2003-06-23 2011-04-15 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
US7595081B1 (en) 2003-10-17 2009-09-29 Bellar Willis F Non-flour containing baked and related food compositions
EP1718331A4 (en) 2004-02-06 2009-11-11 Greer Lab Inc METHOD AND COMPOSITIONS FOR DOSING ALLERGENS
CA2643925A1 (en) * 2006-02-27 2007-08-30 South Georgia Pecan Company Animal food composition comprising nut shell
EP1872792A1 (en) 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
CN101646418B (zh) * 2006-10-12 2013-07-17 昆士兰大学 调节免疫应答的组合物和方法
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
EP2224953A1 (en) 2008-01-02 2010-09-08 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
EP3097927B1 (en) 2008-02-01 2023-05-03 Murdoch Childrens Research Institute A method of inducing tolerance to an allergen
EP2140880B1 (en) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification of allergens
US8802056B2 (en) 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
JP5805363B2 (ja) 2009-06-26 2015-11-04 和興フィルタテクノロジー株式会社 可溶性凝集体、免疫寛容誘導剤及びその製造方法
IN2012DN00878A (sr) * 2009-08-18 2015-05-22 Nestec Sa
EP2475382B1 (en) * 2009-09-07 2015-01-14 DBV Technologies Method of treating eosinophilic esophagitis
CN102048077A (zh) 2009-10-30 2011-05-11 梁振 一种方便营养果丁豆花
CN107184971A (zh) 2010-04-30 2017-09-22 艾洛维特有限责任公司 经由口腔粘膜变应性脱敏的方法、制品和试剂盒
EP2563390A4 (en) * 2010-04-30 2014-05-14 Allovate Llc METHOD AND ARTICLE FOR PREVENTING OR REDUCING THE RISK OF DEVELOPING A HYPERALGENIC IMMUNE SYSTEM
GB201009368D0 (en) 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
EP2987501A1 (en) 2010-10-15 2016-02-24 Alk-Abelló A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CN102986802A (zh) 2012-12-11 2013-03-27 崔杰 一种花生核桃咸饼的制作方法
AU2014240404B2 (en) 2013-03-14 2016-07-21 Societe Des Produits Nestle S.A. Manufacture of peanut formulations for oral desensitization
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
CN105120898A (zh) 2013-03-19 2015-12-02 生物技术工具公司 过敏原制剂
US20150050301A1 (en) 2013-06-06 2015-02-19 Anergis S.A. Contiguous Overlapping Peptides for Treatment of House Dust Mites Allergy
US10485867B2 (en) 2013-09-19 2019-11-26 Allovate, Llc Toothpaste for delivery of allergens to oral mucosa
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
KR102425265B1 (ko) 2014-08-25 2022-07-26 에이뮨 테라퓨틱스, 인코퍼레이티드 난 단백질 제형 및 이의 제조 방법
CN104273238A (zh) 2014-09-27 2015-01-14 合肥市凤落河豆制食品有限公司 一种芝麻酱干及其制备方法
CN107405394B (zh) 2015-02-20 2021-12-14 斯坦福大学托管董事会 混合变应原组合物及其使用方法
US11452774B2 (en) * 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) * 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) * 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2016138030A2 (en) 2015-02-23 2016-09-01 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens

Also Published As

Publication number Publication date
JP2022125346A (ja) 2022-08-26
EP3258962A4 (en) 2018-07-11
US9731003B2 (en) 2017-08-15
CN114129720A (zh) 2022-03-04
JP6859261B2 (ja) 2021-04-14
PT3258962T (pt) 2023-02-16
CN107405394B (zh) 2021-12-14
IL253976A0 (en) 2017-10-31
US20170056494A1 (en) 2017-03-02
SI3258962T1 (sl) 2023-07-31
SG10201909093XA (en) 2019-11-28
US20190038741A1 (en) 2019-02-07
JP2018505907A (ja) 2018-03-01
US20220133882A1 (en) 2022-05-05
BR112017017894A2 (pt) 2018-04-10
FI3258962T3 (fi) 2023-04-12
HK1247854A1 (zh) 2018-10-05
ES2937287T3 (es) 2023-03-27
EP3258962A2 (en) 2017-12-27
JP2021046445A (ja) 2021-03-25
MX2017010697A (es) 2017-11-17
IL253976B1 (en) 2024-05-01
MA41558B1 (fr) 2023-02-28
WO2016134291A2 (en) 2016-08-25
CN107405394A (zh) 2017-11-28
CA2977127A1 (en) 2016-08-25
EP3258962B1 (en) 2022-11-02
DK3258962T3 (da) 2023-02-06
WO2016134291A3 (en) 2016-10-13
LT3258962T (lt) 2023-02-27
AU2016219793A1 (en) 2017-08-31
AU2016219793B2 (en) 2021-12-16
US20160243217A1 (en) 2016-08-25
AU2022201699A1 (en) 2022-04-07
SG11201706734SA (en) 2017-09-28
EP4186521A1 (en) 2023-05-31
US10064936B2 (en) 2018-09-04
HUE061576T2 (hu) 2023-07-28
MX2022008663A (es) 2022-08-10
KR20170117562A (ko) 2017-10-23
PL3258962T3 (pl) 2023-04-24
MA41558A (fr) 2017-12-26
AU2016219793C1 (en) 2022-03-17

Similar Documents

Publication Publication Date Title
HK1247854A1 (zh) 混合變應原組合物及其使用方法
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
HK1253306A1 (zh) 抗ntb-a抗體及相關組合物和方法
GB201513304D0 (en) Compositions and Methods
IL246879B (en) Preparations of Epilimod and methods of using them
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
GB201706355D0 (en) Methods compositions and uses relating thereto
IL266672A (en) Liquid allergen preparations and methods for their preparation
GB201706356D0 (en) Methods compositions and uses relating thereto
GB201706352D0 (en) Methods compositions and uses relating thereto
HK1247136A1 (zh) 包含15-hepe的組合物和其使用方法
GB2550632B (en) Compositions and uses and methods relating thereto
PT3113774T (pt) Composições de grapiprant e métodos de utilização das mesmas
GB201705626D0 (en) Compositions and methods
IL272033B1 (en) Methods for the preparation of mixed allergen preparations
ZA201807665B (en) Methods and compositions
GB201715785D0 (en) Methods compositions and uses relating thereto
GB201715820D0 (en) Compositions and methods
GB201512996D0 (en) Compositions and methods
GB201514413D0 (en) Compositions and methods
ZA201807782B (en) Methods and compositions
GB201514415D0 (en) Compositions and methods